| Primary |
| Cheilitis |
20.5% |
| Stomatitis |
20.5% |
| Cervix Carcinoma Recurrent |
13.6% |
| Vaginal Discharge |
13.6% |
| Nausea |
9.1% |
| Haemoglobin |
6.8% |
| Prophylaxis |
4.5% |
| Pyrexia |
4.5% |
| Vomiting |
4.5% |
| Peritonitis Bacterial |
2.3% |
|
| Extrapyramidal Disorder |
60.0% |
| Dyskinesia |
40.0% |
|
| Secondary |
| Product Used For Unknown Indication |
16.4% |
| Drug Use For Unknown Indication |
16.2% |
| Nausea |
10.0% |
| Premedication |
7.9% |
| Drug Exposure During Pregnancy |
6.3% |
| Breast Cancer |
5.1% |
| Diarrhoea |
4.6% |
| Depression |
4.5% |
| Vomiting |
4.4% |
| Gastritis |
3.6% |
| Oesophagitis |
2.8% |
| Pain |
2.8% |
| Prophylaxis |
2.7% |
| Chemotherapy |
2.3% |
| Pyrexia |
2.0% |
| Epilepsy |
1.9% |
| Hiv Infection |
1.7% |
| Malignant Glioma |
1.7% |
| Hyperlipidaemia |
1.6% |
| Hypertension |
1.6% |
|
| Toxic Epidermal Necrolysis |
14.8% |
| Liver Disorder |
8.2% |
| Toxic Skin Eruption |
8.2% |
| Hypothyroidism |
7.4% |
| Thrombocytopenia |
7.4% |
| Agranulocytosis |
4.9% |
| Premature Baby |
4.9% |
| Hepatitis Acute |
4.1% |
| Off Label Use |
4.1% |
| Rhabdomyolysis |
4.1% |
| Transient Ischaemic Attack |
4.1% |
| Vomiting |
4.1% |
| Cholestasis |
3.3% |
| Lung Disorder |
3.3% |
| Pancreatitis Acute |
3.3% |
| Renal Failure Acute |
3.3% |
| Staphylococcal Infection |
3.3% |
| Abnormal Behaviour |
2.5% |
| Cytolytic Hepatitis |
2.5% |
| Dyskinesia |
2.5% |
|
| Concomitant |
| Prophylaxis |
19.9% |
| Product Used For Unknown Indication |
18.6% |
| Drug Use For Unknown Indication |
7.4% |
| Pain |
6.6% |
| Nausea |
6.2% |
| Constipation |
5.2% |
| Multiple Myeloma |
4.4% |
| Hypertension |
4.4% |
| Hepatitis C |
4.3% |
| Cancer Pain |
3.5% |
| Ovarian Cancer Recurrent |
2.8% |
| Insomnia |
2.6% |
| Colorectal Cancer |
2.4% |
| Vomiting |
2.2% |
| Premedication |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Renal Cell Carcinoma |
1.5% |
| Breast Cancer |
1.4% |
| Diabetes Mellitus |
1.3% |
|
| Vomiting |
11.9% |
| White Blood Cell Count Decreased |
11.6% |
| Thrombocytopenia |
7.3% |
| Nausea |
6.6% |
| Pyrexia |
6.4% |
| Renal Failure Acute |
4.7% |
| Renal Impairment |
4.7% |
| Pneumonia |
4.6% |
| Renal Failure |
4.3% |
| Interstitial Lung Disease |
3.9% |
| Stomatitis |
3.9% |
| Decreased Appetite |
3.8% |
| Febrile Neutropenia |
3.8% |
| Anaemia |
3.6% |
| Sepsis |
3.6% |
| Platelet Count Decreased |
3.2% |
| Pneumothorax |
3.2% |
| Intestinal Obstruction |
3.1% |
| Rash |
2.9% |
| Respiratory Failure |
2.9% |
|
| Interacting |
| Pain |
15.9% |
| Atrial Fibrillation |
15.0% |
| Insomnia |
11.2% |
| Rhinitis Allergic |
11.2% |
| Urinary Tract Infection |
11.2% |
| Nausea |
9.3% |
| Migraine |
6.5% |
| Depression |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Surgery |
4.7% |
| Angina Pectoris |
3.7% |
| Ill-defined Disorder |
0.9% |
| Neoplasm |
0.9% |
|
| Drug Interaction |
38.1% |
| Arrhythmia |
14.3% |
| Drug Level Increased |
9.5% |
| Electrocardiogram Qt Prolonged |
9.5% |
| Myocardial Fibrosis |
9.5% |
| Vomiting |
9.5% |
| Dyspnoea |
4.8% |
| Myoclonus |
4.8% |
|
